CAMPOSTRINI, Natascia
 Distribuzione geografica
Continente #
NA - Nord America 4.740
EU - Europa 3.819
AS - Asia 2.784
SA - Sud America 407
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 55
OC - Oceania 7
Totale 11.872
Nazione #
US - Stati Uniti d'America 4.654
RU - Federazione Russa 1.444
SG - Singapore 1.078
GB - Regno Unito 892
CN - Cina 874
BR - Brasile 323
VN - Vietnam 253
SE - Svezia 252
HK - Hong Kong 238
FR - Francia 228
IT - Italia 227
DE - Germania 202
IE - Irlanda 185
FI - Finlandia 183
KR - Corea 79
UA - Ucraina 63
JP - Giappone 61
CA - Canada 51
IN - India 45
AR - Argentina 35
NL - Olanda 30
TR - Turchia 28
BD - Bangladesh 26
BE - Belgio 24
ES - Italia 21
IQ - Iraq 18
NG - Nigeria 17
PL - Polonia 17
MX - Messico 16
ZA - Sudafrica 14
ID - Indonesia 12
EC - Ecuador 10
IR - Iran 9
PK - Pakistan 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CO - Colombia 7
MA - Marocco 7
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
UY - Uruguay 6
CH - Svizzera 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
HN - Honduras 4
HR - Croazia 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
SI - Slovenia 4
TN - Tunisia 4
GR - Grecia 3
JM - Giamaica 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
GD - Grenada 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 11.813
Città #
Southend 733
Singapore 616
Chandler 513
Jacksonville 481
Moscow 478
Ashburn 407
San Jose 404
Woodbridge 340
Dallas 297
Ann Arbor 234
Hong Kong 233
Houston 198
Dublin 184
Beijing 166
Council Bluffs 160
Verona 125
New York 106
The Dalles 103
Ho Chi Minh City 92
Lawrence 77
Princeton 77
Los Angeles 73
Wilmington 69
Lancaster 63
Nanjing 61
Jinan 59
Tokyo 59
Hanoi 51
Santa Clara 49
Munich 48
Boardman 39
São Paulo 35
Shenyang 34
Buffalo 32
Helsinki 31
Columbus 29
Tianjin 26
Nanchang 25
Redondo Beach 24
Orem 23
Brussels 22
Hebei 22
Montreal 22
Sindelfingen 21
Brooklyn 20
Changsha 20
Hangzhou 20
Jiaxing 20
Haikou 19
Milan 19
Zhengzhou 19
Guangzhou 18
Chennai 16
Ningbo 16
Norwalk 16
London 15
Taizhou 15
Abuja 14
Seattle 14
Turku 14
Atlanta 13
Taiyuan 13
Toronto 13
Warsaw 13
Amsterdam 12
Bologna 12
Denver 12
Redmond 12
Rio de Janeiro 12
San Francisco 12
Poplar 11
Stockholm 11
Boston 10
Chicago 10
Lanzhou 10
Manchester 10
Fairfield 9
Haiphong 9
San Mateo 9
Shanghai 9
Dhaka 8
Fuzhou 8
Hải Dương 8
Johannesburg 8
Ankara 7
Brasília 7
Dearborn 7
Madrid 7
Phoenix 7
Washington 7
Ardabil 6
Baghdad 6
Barnet 6
Belo Horizonte 6
Can Tho 6
Falls Church 6
Frankfurt am Main 6
Miami 6
Montevideo 6
Nuremberg 6
Totale 7.572
Nome #
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 225
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. 223
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 220
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 213
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 211
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 210
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 209
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 208
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 206
The proteome: anno Domini 2002 196
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 194
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 194
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism 194
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 193
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 192
Altered paraoxonase expression in patients with genetic haemochromatosis. 192
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 191
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 188
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing. 185
High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice 184
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 180
“Proteomics approaches for studying chemoresistance in cancer” 175
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells 174
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. 171
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 171
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 170
"Quantitative Proteomics" 168
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 168
“Application of Partial Least Squares Discriminant Analysis and variable selection procedures: a 2D-PAGE Proteomic-Based Study” 165
“Pre-fractionation for Hidden Proteome” 163
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. 162
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience 162
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 161
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 161
Serum Hepcidin in Inflammatory Bowel Diseases: biological and clinical significance. 160
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy 160
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 159
Association ofHFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. 157
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity 157
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report. 155
Does TMPRSS6 RS855791 Polymorphism Contribute to Iron Deficiency in Treated Celiac Disease? 154
Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin 150
Hepcidin levels and their determinants in different types of myelodysplastic syndromes. 149
“Numerical approaches for quantitative analysis of 2D map: a review of commercial software and of “home-made” systems” 146
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 146
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 144
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. 144
Reduced serum hepcidin levels in patients with chronic hepatitis C 139
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 138
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 136
Proteomic analysis of S-nitrosylated proteins in Arabidopsis during the disease resistance response 135
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 133
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 128
Quantitative proteomics: a review of different methodologies. 125
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. 125
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. 124
Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. 121
Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods. 121
Formation of truncated proteins and high-molecular-mass aggregates upon soft illumination of photosynthetic proteins. 118
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material 113
Iron deficiency in the elderly population, revisited in the hepcidin era. 112
Omics | quantitative proteomics 112
Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. 110
Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study. 110
Two-dimensional mapping as a tool for classification of green coffee bean species. 109
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 107
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo 106
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 105
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 103
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 103
Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient 103
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. 102
PON1 activity and coagulation biomarkers: no association with thrombin generation parameters but an inverse correlation with D-dimer plasma concentration 101
Hepcidin levels in chronic hemodialysis patients: a critical evaluation. 99
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization 97
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 95
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) 94
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. 88
Totale 11.872
Categoria #
all - tutte 39.771
article - articoli 29.533
book - libri 0
conference - conferenze 8.232
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.006
Totale 79.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022513 0 145 11 65 20 16 6 27 20 15 62 126
2022/20231.345 90 142 129 216 146 317 23 79 156 4 27 16
2023/2024603 24 48 39 51 76 126 14 35 4 11 120 55
2024/20251.497 67 103 63 274 62 68 60 46 233 84 125 312
2025/20264.733 344 283 350 866 1.207 286 454 235 295 240 47 126
2026/2027212 69 143 0 0 0 0 0 0 0 0 0 0
Totale 11.872